[Regional pulmonary function in unilateral sero-fibrinous pleural effusions and changes under the influence of treatment (author's transl)]. 1981

A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin

The regional distribution of ventilation (Vr), perfusion (Qr) (expressed in absolute values) and the regional distribution of ventilated lung volume, of ventilation and of perfusion (expressed as %) were studied using Xenon 133 in 13 subjects with a unilateral pleural effusion of proven or presumed tuberculous origin. The examinations were performed in a sitting position. The initial examination was carried out after as complete an evacuation as possible of the fluid effusion. Eight subjects underwent a follow-up examination after two months treatment with tuberculostatic agents combined with daily respiratory physiotherapy. The initial results emphasized the following points: - in absolute values, a deficit in ventilation on the involved side affecting the 3 regions explored without any similar change in perfusion ; a hyperventilation on the controlateral upper and middle regions ; - in relative values, a slight deficit in ventilated volume and perfusion localised at the base, whilst the deficit in ventilation was more marked and more extensive. After treatment the contribution to ventilation of the involved side increased on average by 6%. However this improvement only concerned the lower territory. The mechanisms of impairment of regional function and its improvement under the influence of treatment are discussed.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D014692 Ventilation-Perfusion Ratio The ratio of alveolar ventilation to simultaneous alveolar capillary blood flow in any part of the lung. (Stedman, 25th ed) Ratio, Ventilation-Perfusion,Ratios, Ventilation-Perfusion,Ventilation Perfusion Ratio,Ventilation-Perfusion Ratios

Related Publications

A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
January 1972, Le Poumon et le coeur,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
January 1964, Revue de tuberculose et de pneumologie,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
July 1964, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
January 1954, Revue de la tuberculose,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
October 1974, Thoraxchirurgie, vaskulare Chirurgie,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
December 1979, La Radiologia medica,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
June 1977, Clinica chimica acta; international journal of clinical chemistry,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
November 1979, Therapeutische Umschau. Revue therapeutique,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
January 1980, Plucne bolesti i tuberkuloza,
A Vandevenne, and B Moyses, and E Weitzenblum, and I Carloz, and G Methlin
August 1973, Therapeutische Umschau. Revue therapeutique,
Copied contents to your clipboard!